Authors


Thomas P. Bravo, MD

Latest:

PACAP: Lessons From A Potent Migraine Inducer?

PACAP38 is a potent aggravator of migraine, a new study shows. This provides several new potential therapeutic targets -- most prominently a specific PACAP receptor PAC1.


Todd J. Schwedt, MD

Latest:

Poor Acute Treatment May Lead to Chronic Migraine

Efficacy of acute medication matters beyond just treating a single migraine. It may increase the risk of worsened disease.


Veronica Hackenthal, MD

Latest:

New Type of Chronic Daily Headache in Older Women?

This case series appears to identify a new subtype of chronic daily headache in overweight/obese women in their fifties and sixties.


Veronica Hackethal MD

Latest:

Probing Headaches: A Diagnostic Challenge Quiz

What differentiates migraine from underlying intracranial pathology that may require neuroimaging, like tumors, abscesses, aneurysms, or hemorrhages? Test your skills with this 5-question quiz.


Veronica Hackethal, MD

Latest:

Chronic Migraine Out of Control Despite Multiple Drug Trials

Your patient asks if a ketogenic diet can reduce her migraines. What will you tell her?


Yuebing Li, MD

Latest:

Finding Consensus: Treating Myasthenia Gravis

The author discusses MG disease classifications as well as treatment goals and treatment adherence.


Dilan Athauda, MBBS, MRCP, BSc

Latest:

Exenatide for Parkinson Symptoms: Early Results Are Positive

Exenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.


Pradeep N. Modur, MD, MS

Latest:

Leveraging Technology to Improve Epilepsy Treatment: Responsive Neurostimulation

An update on responsive neurostimulation, the only implantable, closed-loop device approved for treating seizures.


Thomas Foltynie, PhD, MD

Latest:

Exenatide for Parkinson Symptoms: Early Results Are Positive

Exenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.


Amy Kao, MD

Latest:

Dietary Therapy to Improve Epilepsy Outcomes: Case Vignettes

The authors present illustrative fictional accounts of patients with medical problems with co-occurring epilepsy.


Brittany Cines, RD, LD, CNSC, CSP

Latest:

Dietary Therapy to Improve Epilepsy Outcomes: Case Vignettes

The authors present illustrative fictional accounts of patients with medical problems with co-occurring epilepsy.


Amit Ban

Latest:

Case Study: Siblings With Hypotonia in All Limbs

Two young siblings presented to the pediatric department with mental retardation, developmental delay, ataxia, and nystagmus since birth. What's your diagnosis after reviewing the case?


Shawn Marshall, MD, MSc

Latest:

Eight Key Features of Post-Concussion Care

It is often unclear which treatments are most appropriate for the constellation of concussion symptoms. Thus, evidence-based education as well as treatment and management options to facilitate recovery are required.


Heather Zwickey, PhD

Latest:

6 Essential Nutrition Recommendations for Parkinson Disease

This article provides some straightforward nutritional recommendations that neurologists can share with their patients.


Kathleen M. Shannon, MD, FAAN, FANA

Latest:

The Gut Has It: Microbes and Parkinson

While it is premature to conclude that changes in intestinal microbes influence the genesis or progression of PD, preliminary evidence indicates that they may be associated with inflammation in the intestinal wall.


David Y. Hwang, MD

Latest:

Top Issues in Emergency Neurology Today

Neurology on the front lines engages patients and their families in a shared decision-making process regarding goals of care.


Tracy T. Batchelor, MD

Latest:

Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical Implications

Primary central nervous system lymphoma (PCNSL) is a rare but aggressive malignancy that accounts for approximately 3% of all primary CNS cancer. New studies have changed the landscape of PCNSL treatment paradigms and expectations for outcome.


Michael W. Parsons, PhD

Latest:

Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical Implications

Primary central nervous system lymphoma (PCNSL) is a rare but aggressive malignancy that accounts for approximately 3% of all primary CNS cancer. New studies have changed the landscape of PCNSL treatment paradigms and expectations for outcome.


Kasra Maasumi, MD, MS

Latest:

Treating Menstrual Migraines

Given the severity and treatment resistance of menstrual migraine, clinicians should watch for the signs and symptoms discussed in this case.


Patrick W. Hullett, MD, PhD

Latest:

Treating Menstrual Migraines

Given the severity and treatment resistance of menstrual migraine, clinicians should watch for the signs and symptoms discussed in this case.


Murtaza Khan, MD

Latest:

Differential Diagnosis of Meningitis and Encephalitis

The authors distinguish between the clinical entities of meningitis, encephalitis, and encephalopathy.


Amanda L Piquet, MD

Latest:

Differential Diagnosis of Meningitis and Encephalitis

The authors distinguish between the clinical entities of meningitis, encephalitis, and encephalopathy.


Shin C. Beh, MD

Latest:

Thrown Around by the Devil

For the past year, a patient lived in such utter fear of her symptoms that she became housebound.


Darrin J. Lee, MD, PhD

Latest:

Mini Quiz: Deep Brain Stimulation for Memory Impairment

Which brain regions are potential deep brain stimulation targets for neurological disorders with memory impairment? Take the quiz and learn more.


Linda Peckel

Latest:

Sleep Deprivation Among Frontline Health Care Workers During COVID-19 Turns Critical

The pandemic's impact stretches across all aspects of life, and has particularly concerning effects on the sleep of those working on the frontlines providing care of patients.


Janelle L Wagner, PhD

Latest:

Addressing Behavioral Health Issues in Pediatric Epilepsy

The highest level of comprehensive care targets youths with epilepsy who have known comorbid psychiatric, developmental, and cognitive disorders and/or a history of nonadherence to seizure medication.


Chelsea Weyand, PsyD, ABPP

Latest:

Addressing Behavioral Health Issues in Pediatric Epilepsy

The highest level of comprehensive care targets youths with epilepsy who have known comorbid psychiatric, developmental, and cognitive disorders and/or a history of nonadherence to seizure medication.


Howard S. Kirshner, MD

Latest:

A Case of Cerebral Amyloid Angiopathy-Related Inflammation With Pathologic Features

A 71-year-old woman presented to the emergency department with subacute headaches and altered behavior that was initially attributed to emotional distress. What did the tests show?


Michael J. Bradshaw, MD

Latest:

A Case of Cerebral Amyloid Angiopathy-Related Inflammation With Pathologic Features

A 71-year-old woman presented to the emergency department with subacute headaches and altered behavior that was initially attributed to emotional distress. What did the tests show?


Matthew Schrag, MD, PhD

Latest:

The Next Wave of Stroke Care Beyond the Acute Phase: Matthew Schrag, MD, PhD

The associate professor of neurology at Vanderbilt University Medical Center discussed exploring promising opportunities in other phases outside of the acute phase of ischemic stroke. [WATCH TIME: 3 minutes]

© 2024 MJH Life Sciences

All rights reserved.